Adalimumab (Humira)
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Adalimumab (Humira), covering 2007-08-29 to 2016-11-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting [Phase 3]